$QSI News
Last published 6d ago
- 6d agoQSIQuantum-Si Inc - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 6d agoQSIQuantum-Si Reports Third Quarter 2026 Financial Results and Provides Business UpdateGlobeNewswireQuantum-Si Reports Third Quarter 2026 Financial Results and Provides Business Update. Proteus™ remains on track for anticipated Q2 2027 commercial...
- 6d agoQSIQuantum-Si Reports Third Quarter 2026 Financial Results and Provides Business UpdateGlobeNewswireBRANFORD, Conn., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis
- 3w agoQSIQuantum-Si to Provide a Business Update and Report Third Quarter 2026 Financial Results on November 5, 2026GlobeNewswireBRANFORD, Conn., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis
- 3w agoQSIQuantum-Si Regains Compliance with Nasdaq Minimum Bid Price RequirementGlobeNewswireBRANFORD, Conn., Oct. 15, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI," or the "Company"), a proteomics company redefining protein analysis through
- 1mo agoQSIQuantum-Si Demonstrates Detection of 19 Amino Acids in Proteus™ Development ProgramGlobeNewswireBRANFORD, Conn., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics company redefining protein analysis through
- 1mo agoQSIQSI WORLD HUPO 2026 - QUANTUM-SI INCEarnings Call TranscriptsLet me start with trying to orient you to maybe the fundamental engineering architecture. Since the chemistry approach is very similar on the platforms, I want to make sure you understand the conversion we've made. So th
- 1mo agoQSIQuantum-Si Announces Detection of 18 Amino Acids Using a Developmental Sequencing Kit on Proteus™GlobeNewswireBRANFORD, Conn., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics company redefining protein analysis through
- 2mo agoQSIQuantum-Si Expands Proteus™ Roadshow with Additional U.S. and European CitiesGlobeNewswireBRANFORD, Conn., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis
- 2mo agoQSIQuantum-Si to Participate in the H.C. Wainwright 28th Annual Global Investment ConferenceGlobeNewswireBRANFORD, Conn., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis
- 3mo agoQSIQuantum-Si Q2 2026 Earnings Call - QUANTUM-SI INCEarnings Call TranscriptsGood day and thank you for standing by. Welcome to the Quantum SI second quarter 2026 earnings call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question an
- 3mo agoQSIQuantum-Si Reports Second Quarter 2026 Financial Results and Provides Proteus™ Development UpdateGlobeNewswireCompany updates anticipated commercial launch of Proteus to Q2 2027, cost-reduction actions expected to extend cash runway into Q4 2028 and highlights estimated new market opportunities for protein sequencing BRANFORD,
- 3mo agoQSIQuantum-Si to Report Second Quarter 2026 Financial Results on August 13, 2026GlobeNewswireBRANFORD, Conn., July 27, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis
- 4mo agoQSIQuantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business WireQuantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced that the Compensation Committee of
- 5mo agoQSIQuantum-Si and Cell Signaling Technology Partner to Advance Post-Translational Modification Analysis on Proteus™Business WireQuantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced a partnership with Cell Signaling
- 5mo agoQSIQuantum-Si Announces the Expansion of the Proteus™ RoadshowBusiness WireMulti-City Roadshow is Driving Awareness of Proteus and Developing Customer Funnel for Commercial Launch Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company
- 6mo agoQSIQuantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business WireQuantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced that the Compensation Committee
- 6mo agoQSIQuantum-Si Q1 2026 Earnings Call - QUANTUM-SI INCEarnings Call TranscriptsGood day, and thank you for standing by. Welcome to the Quantum SI First Quarter 2026 Earnings Call and Business Update. At this time, all participants are in a listen-only mode. After the speaker's presentation, there w
- 6mo agoQSIQuantum-Si Reports First Quarter 2026 Financial Results and Highlights Proteus™ Development MilestonesBusiness WireSuccessful sequencing on integrated Proteus instruments and continued progress toward amino acid coverage and overall launch capabilities Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a
- 6mo agoQSIQuantum-Si to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQBusiness WireQuantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced that it will be participating in
- 6mo agoQSIQuantum-Si Announces Successful Sequencing on Integrated Proteus™ InstrumentsBusiness WireQuantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced that the company has successfully
- 6mo agoQSI2025 Quantum Si Investors and Analysts Day - QUANTUM-SI INCEarnings Call TranscriptsAll right. Good morning, everybody. Appreciate everyone being here in person. And for those online, welcome as well. I want to kick off today, give you a quick overview of what we're going to accomplish during this prese
- 6mo agoQSIQuantum-Si to Report First Quarter 2026 Financial Results on May 7, 2026Business WireQuantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it will report financial
- 7mo agoQSIQuantum-Si Announces Two Customer Posters to be Presented at the American Association of Cancer Research Annual MeetingBusiness WireQuantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced that there will be two customer
- 7mo agoQSIQuantum-Si Announces New Manuscript Demonstrating the Value of Single-molecule Protein Sequencing to Aid in Identifying New Cancer Treatment StrategiesBusiness WireQuantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced a new manuscript available via
- 7mo agoQSIQuantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business WireQuantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced that the Compensation Committee
- 7mo agoQSIQuantum-Si Announces First Customer Samples Tested on the Proteus™ Prototype SystemBusiness WireSequencing Results Utilizing a Proteus Prototype System Exceeds Platinum® Pro Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein
- 7mo agoQSIQuantum-Si Announces the Start of the Proteus™ RoadshowBusiness WireMulti-city Roadshow To Drive Awareness of Proteus and Develop Customer Funnel for Commercial Launch Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company
- 8mo agoQSIQuantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business WireQuantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that the Compensation Committee
- 8mo agoQSIQuantum-Si (QSI) Q4 & Year-End 2025 Earnings Call - QUANTUM-SI INCEarnings Call TranscriptsThank you for standing by, and welcome to the Quantum SI fourth quarter and year-end 2025 earnings call. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a question-
- 8mo agoQSIQuantum-Si Reports Fourth Quarter and Full Year 2025 Financial ResultsBusiness WireReleases List Price of Proteus™ Platform Reiterates Proteus Development Program On Track for Year End 2026 Launch Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics
- 9mo agoQSIQuantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business WireQuantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that the Compensation Committee
- 9mo agoQSIQuantum-Si to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026Business WireQuantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it will report financial
- 9mo agoQSIQuantum-Si Announces the Release of Two New Manuscripts Demonstrating the Value of Single-Molecule Protein Sequencing in Clinical Proteomics and Pathogen & Toxin DetectionBusiness WireQuantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced two new manuscripts have been
- 10mo agoQSIQuantum-Si Announces Launch of New Version 3 Library Preparation Kit and a Suite of Data Analysis Tool EnhancementsBusiness WireNew library prep kit enables detection of proteins with as little as 1-2 ng of input Data analysis enhancements unlock new amino acid detection Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the
- 11mo agoQSIQuantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business WireQuantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that the Compensation Committee
- 11mo agoQSIQuantum-Si Highlights Significant Development Advancements for Proteus™ and Industry Leading Technology Pipeline at Investor & Analyst DayBusiness WireExpect Proteus launch by end of 2026 Demonstration of the detection of all 20 amino acids by end of 2026 New controlled cleavage chemistry unlocks path to billions of sequencing reads Quantum-Si Incorporated
- 11mo agoQSIQuantum-Si to Highlight Significant Proteus™ Platform Development Progress and Provide Insights into the Company's Industry Leading Technology Pipeline at Investor & Analyst DayBusiness WireQuantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced the key items to be presented
- 1y agoQSIQuantum-Si Reports Third Quarter 2025 Financial ResultsBusiness WireAnnounces Successful Sequencing on Prototype Proteus Unit, Development Program Remains On-Track Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining
- 1y agoQSIQuantum-Si Q3 Earnings Call - QUANTUM-SI INCEarnings Call TranscriptsGood day and thank you for standing by. Welcome to the Quantum SI third quarter earnings conference call. At this time, all participants are in the listen-only mode. After the speaker's presentation, there will be a ques
- 1y agoQSIQuantum-Si to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumBusiness WireQuantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it
- 1y agoQSIQuantum-Si to Report Third Quarter 2025 Financial Results on November 5, 2025Business WireQuantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it will report financial
- 1y agoQSIQuantum-Si to Host Investor & Analyst Event in New York City on November 19, 2025Business WireQuantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that
- 1y agoQSIQuantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business WireQuantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that the Compensation Committee
- 1y agoQSIQuantum-Si Announces the Launch of V4 Sequencing Kit, Expanding Proteome Coverage and Unlocking New Applications for Protein SequencingBusiness WireQuantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced the launch of the V4 Sequencing
- 1y agoQSIQuantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business WireQuantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that the Compensation Committee
- 1y agoQSIQuantum-Si to Participate in the UBS Precision Medicine Frontiers SummitBusiness WireQuantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it
- 1y agoQSIQuantum-Si incorporated (QSI) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoQSIQuantum-Si Reports Second Quarter 2025 Financial ResultsBusiness WireAnnounced On-Track ProteusTM Development Program Completes Capital Raise of $50 Million Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein
- 1y agoQSIQuantum-Si to Report Second Quarter 2025 Financial Results on August 5, 2025Business WireQuantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it will report financial